Latest Lead News

Finexia Financial Group announces the resignation of Interim CEO Marc Duncan as the Board intensifies its review of credit operations and pursues ASX securities reinstatement.

A shareholder has lodged an application with the Takeovers Panel challenging FBR Limited’s upcoming extraordinary general meeting resolutions related to significant share placements and funding arrangements with Fidelity International.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.

FXG has announced a $17 million two-tranche placement priced at A$0.155 per share, aimed at advancing drilling and exploration activities in Alaska. The second tranche awaits shareholder approval, marking a pivotal funding milestone for the company.

Felix Gold Limited has successfully raised $17 million through a two-tranche placement, bolstering its cash reserves to advance exploration and development in Alaska’s prolific Fairbanks Gold District.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

ABx Group has discovered a new rare earth element province 52 km east of its Deep Leads resource in northern Tasmania, revealing exceptionally high grades of terbium and dysprosium critical for advanced technologies. This discovery aligns with shifting global supply dynamics amid US incentives and Chinese export restrictions.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Venus Metals Corporation’s subsidiary Redscope has won a $52,500 grant from the WA Government to co-fund diamond drilling at the Pincher Copper Project, targeting a significant geophysical anomaly. Drilling is set to begin in June 2025, advancing exploration of a promising volcanogenic massive sulphide system.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.